7YJS image
Entry Detail
PDB ID:
7YJS
Keywords:
Title:
Crystal structure of MCR-1-S treated by sodium aurothiosulfate
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2022-07-20
Release Date:
2023-02-01
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.30
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Probable phosphatidylethanolamine transferase Mcr-1
Chain IDs:A, B
Chain Length:336
Number of Molecules:2
Biological Source:Escherichia coli
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
TPO A THR modified residue
Ligand Molecules
Primary Citation
Gold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria.
J.Biol.Inorg.Chem. 28 225 234 (2023)
PMID: 36662362 DOI: 10.1007/s00775-022-01983-y

Abstact

The emergence and rapid spread of the mobile colistin resistance gene mcr-1 among bacterial species and hosts significantly challenge the efficacy of "last-line" antibiotic colistin. Previously, we reported silver nitrate and auranofin serve as colistin adjuvants for combating mcr-1-positive bacteria. Herein, we uncovered more gold-based drugs and nanoparticles, and found that they exhibited varying degree of synergisms with colistin on killing mcr-1-positive bacteria. However, pre-activation of the drugs by either glutathione or N-acetyl cysteine, thus releasing and accumulating gold ions, is perquisite for their abilities to substitute zinc cofactor from MCR-1 enzyme. X-ray crystallography and biophysical studies further supported the proposed mechanism. This study not only provides basis for combining gold-based drugs and colistin for combating mcr-1-positive bacterial infections, but also undoubtedly opens a new horizon for metabolism details of gold-based drugs in overcoming antimicrobial resistance.

Legend

Protein

Chemical

Disease

Primary Citation of related structures